Glioblastoma
Showing 2126 - 2150 of 2,245
Glioblastoma Multiforme, Astrocytoma Trial in Duelmen (Imatinib mesylate, Hydroxyurea)
Completed
- Glioblastoma Multiforme
- Astrocytoma
- Imatinib mesylate
- Hydroxyurea
-
Duelmen, GermanyNovartis Investigative Site
Apr 19, 2011
Brain and CNS Tumors Trial in Lyon (temozolomide, hypofractionated radiation therapy, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- temozolomide
- +2 more
-
Lyon, FranceCentre Leon Berard
May 11, 2011
Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Durham (IL13-PE38QQR, targeted fusion protein
Completed
- Malignant Glioma
- +4 more
- IL13-PE38QQR
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jun 2, 2011
Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma Trial in United States (IL13-PE38QQR, Surgery for placement,
Completed
- Glioblastoma Multiforme
- +2 more
- IL13-PE38QQR
- +3 more
-
San Francisco, California
- +5 more
Jun 30, 2011
Brain and CNS Tumors, Breast Cancer, Kidney Cancer Trial run by the CC (carboxyamidotriazole, paclitaxel)
Completed
- Brain and Central Nervous System Tumors
- +8 more
-
Bethesda, Maryland
- +1 more
Mar 14, 2012
Brain and CNS Tumors Trial (Isotretinoin, Procarbazine Hydrochloride)
Withdrawn
- Brain and Central Nervous System Tumors
- Isotretinoin
- Procarbazine Hydrochloride
- (no location specified)
Feb 17, 2012
Glioblastoma Multiforme Trial in Beer Sheva (other, radiation, drug)
Unknown status
- Glioblastoma Multiforme
- Surgery
- +3 more
-
Beer Sheva, IsraelSoroka University Medical Center
Mar 27, 2011
Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in United States (IL13-PE38QQR, targeted fusion protein
Completed
- Malignant Glioma
- +4 more
- IL13-PE38QQR
- +2 more
-
San Francisco, California
- +3 more
Jun 2, 2011
Renal Cell Cancer Trial in Nijmegen (Temsirolimus)
Unknown status
- Renal Cell Cancer
-
Nijmegen, Gelderland, NetherlandsUniversity Medical Centre Nijmegen
Apr 10, 2012
Brain and CNS Tumors Trial in New York (carboplatin, irinotecan HCl, radiation therapy)
Completed
- Brain and Central Nervous System Tumors
- carboplatin
- +2 more
-
New York, New YorkNYU School of Medicine's Kaplan Comprehensive Cancer Center
Mar 25, 2011
Glioblastoma Multiforme Trial in United States (MPC-6827 + Carboplatin)
Unknown status
- Glioblastoma Multiforme
- MPC-6827 + Carboplatin
-
Los Angeles, California
- +4 more
Mar 24, 2011
Glioblastoma Trial (Temozolamide, irinotecan)
Unknown status
- Glioblastoma
- Temozolamide, irinotecan
- (no location specified)
Mar 2, 2011
Establishment of a Brain and Spinal Tumor Tissue Bank
Unknown status
- Glioblastoma Multiforme
- +2 more
-
Taipei, TaiwanTaipei Medical University-Wan Fang Hospital
Apr 11, 2011
Glioblastoma Multiforme Trial (Neuradiab + Radiotherapy + Temozolomide, Radiation Therapy + Temozolomide)
Terminated
- Glioblastoma Multiforme
- Neuradiab + Radiotherapy + Temozolomide
- Radiation Therapy + Temozolomide
- (no location specified)
Feb 8, 2011
Coronary Artery Disease Trial in United States (XIENCE V® Everolimus Eluting Coronary Stent, TAXUS™ EXPRESS2™ Paclitaxel Eluting
Completed
- Coronary Artery Disease
- XIENCE V® Everolimus Eluting Coronary Stent
- TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent
-
Scottsdale, Arizona
- +64 more
Oct 8, 2012
Glioblastoma Multiforme, Astrocytoma Anaplastic Foci Trial (MAB-425 radiolabeled with I-125)
Unknown status
- Glioblastoma Multiforme
- Astrocytoma Anaplastic Foci
- MAB-425 radiolabeled with I-125
- (no location specified)
Mar 16, 2011
Carcinoma Trial in Oslo (MOC31-PE)
Completed
- Carcinoma
-
Oslo, NorwayThe Norwegian Radium Hospital, Department of Clinical Cancer Res
May 3, 2012
Influenza Trial in Puerto Rico, United States (Trivalent inactivated influenza vaccine High Dose, Trivalent inactivated
Terminated
- Influenza
- Trivalent inactivated influenza vaccine High Dose
- Trivalent inactivated influenza vaccine
-
Birmingham, Alabama
- +97 more
Jul 24, 2012
Glioma Trial run by the NCI (PEG-interferon alfa-2b, Thalidomide)
Completed
- Glioma
- PEG-interferon alfa-2b
- Thalidomide
-
Bethesda, MarylandNational Institutes of Health
Sep 19, 2011